Back to Search
Start Over
Nirsevimab shows positive topline results in RSV Phase 2/3 MEDLEY trial
- Source :
- Thomson Reuters ONE. June 28, 2021
- Publication Year :
- 2021
-
Abstract
- (GLOBE NEWSWIRE via COMTEX) -- Nirsevimab shows positive topline results in RSV Phase 2/3 MEDLEY trial - Respiratory syncytial virus (RSV) is the leading cause of hospitalization in all infants1,2 [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Thomson Reuters ONE
- Publication Type :
- News
- Accession number :
- edsgcl.666655402